Trusted Answers for Clinical Decision Support


Medication Errors — and Three Steps to a Process-Focused Cure

The Search for Drug Interactions Screening Effciency at Rio de Janeiro’s Hospital São Vicente de Paulo

Important Update for Latin America on Medication Interactions Checking

Insights From Puerto Rico’s Poison Control Center

NEW Latin America-Focused Clinical Webinar Series — See the Topics and Register Now


Local news and updates
Clinical quiz: Test yourself for a chance to win an Apple® prize
Tips and tricks: Combating alert fatigue
New dengue fever toxicology content
Event recaps from Mexico and Puerto Rico, plus upcoming events

Note From the Editors

Welcome to our second Latin American edition of Micromedex® Insights, with a special focus on the key issue of drug interactions and medication-related errors.

Our leading article presents critical insights, including real-world steps that hospitals can take to prevent medication incidents. We’ve also included an interview with André Mallmann, from the Joint Commission International-accredited São Vicente de Paulo Hospital, on how his organization is tackling effciency and drug interaction issues.

Plus, read on for news on the Zika virus, tips for combating alert fatigue in Micromedex Solutions, more information on this year’s acquisition of Truven Health Analytics™ by IBM®, and much more. And make sure to register for our new clinical webinar series for healthcare professionals, tailored specifically to the unique issues you face in Latin America.

Thank you so much for reading and your continued feedback. We always appreciate suggestions, and if you would like to contribute information for a future issue, please email clara.manosalva@dotlib.com.


The Editors

The Numbers Behind Micromedex

Micromedex Solutions provides trusted, evidence-based clinical decision support to organizations in more than 85 countries across the globe, including Latin America.

Our content is regularly updated by an in-house editorial team of 90+ full-time staff members who are trained to review the world’s most respected biomedical literature. That review process includes up to 500,000 scientifc articles each year and is critical to collecting the evidence-based clinical information supported by the international scientifc community.

What's New

Industry News

News on the Zika Front

The Zika virus has had Latin America on alert for a year and a half. The World Health Organization now says cases have been reported in 23 countries and territories of the American continent, and experts foresee that by 2017, about 4 million people could be affected.

The roadmap to combat the Zika virus was established in Uruguay in March 2016 and agreed to by the health ministers of 14 countries. It emphasizes coordinating the design and execution of public education campaigns, as well as generating shared knowledge and reciprocal support for diagnosing Zika cases.

Marcos Espinal, Director of the Department of Communicable Diseases and Health Analysis at the Pan American Health Organization, said that, without a vaccine and specifc medicine, “the most effcient tool is to minimize the impact of the virus by controlling the proliferation of mosquitos via fumigation and covering the containers in which they reproduce.”

Meanwhile, Truven Health Analytics, an IBM Company, continues to incorporate evidence-based information on the virus into its Micromedex clinical content, including pregnancy risk information, disease and condition management, toxicology information, and education for patient care.

In addition, IBM announced that it is committing powerful resources, technology, and pro bono expertise to help scientists, the public health community, and humanitarian agencies in the fight against the Zika virus. As part of its IBM Impact Grant programs, IBM is providing technology and talent to Brazil’s Oswaldo Cruz Foundation (Fiocruz), a research institution a liated with the Brazilian Ministry of Health and one the most prominent science and technology health institutions in Latin America. Fiocruz plans to help track the spread of Zika by using technology developed by IBM to analyze clues ranging from anecdotal observations recorded by the general public on social media, to offcial data about human travel patterns.

Truven Health Analytics News

More on the IBM Acquisition of Truven Health

Earlier this year, Truven Health was acquired by IBM as a part of its Watson™ Health business unit. This is IBM’s fourth major health data-related acquisition since launching Watson Health in April 2015. The Truven Health acquisition bolsters the business unit’s global talent footprint to more than 5,000 employees, including clinicians, epidemiologists, statisticians, healthcare administrators, policy experts, and healthcare consultants.

Watch this!

Learn more about IBM Watson Health and our vision for cognitive and analytic technology at micromedex.com/IntroIBMWatsonHealth

Thought Leadership

Medication Errors — and Three Steps to a Process-Focused Cure

Industry leaders typically agree that today’s modern healthcare system has made strides in improving patient safety.1 Yet mistakes still happen.

One study by the World Health Organization (WHO) found that 20 percent of the more than 11,000 inpatients analyzed in 58 Latin American hospitals experienced at least one harmful incident during their hospital stay.2

Medication errors continue to be a part of that problem. The same WHO research found that medication-related errors made up nearly 10 percent of the total harmful incidents studied.2

In his book titled El Desorden Sanitario Tiene Cura (There is a Cure to Health Care Disarray), business management specialist Rajaram Govindajaran says he understands how errors are possible today, since focused analysis of the organizational side of healthcare is still young. The study of healthcare processes, Govindajaran says, didn’t begin until the 1980s — and the current quality of medical care and patient safety is closely tied to disorganized and non-standardized processes.

The Role of Detection and Control Systems

A closer look at the role of processes in medication- related errors demonstrates just how important administrative controls and hospital procedures are to the issue. A study conducted by the Sociedad

Española de Farmacia Hospitalaria (Spanish Society of Hospital Pharmacy), using a statistical analysis of 8,222 opportunities, found that the most common medication errors were caused by information discrepancies (35 percent), time errors (33 percent), and registry errors in administration (33 percent).3

For errors that impacted patients, omissions (not administering a necessary drug) were the most common mistakes (4.4 percent), followed by the administering of a non-prescribed dose (4.2 percent), the administering of an inappropriate dose (3.7 percent), an error in the administration technique (0.3 percent), and administering an inappropriate form of the drug (0.2 percent).3 The good news is that there is also a clear, process-focused path to improvement.

Steps to a Cure


Collaborative rethinking of processes

Rethinking patient drug safety in hospitals means rethinking processes. And decreasing the numbers of drug-related incidents starts by establishing a medication system that brings together clinical and administrative procedures, along with other departments and topics related to the handling of medication.

The safe use of medication is often thought of as a pharmacy goal, but it should be a key goal for the entire organization and healthcare professionals, enterprise- wide. Providing patients with the highest possible levels of safety requires the involvement and collaboration of all stakeholders in the system.

Developing a closely connected system involves a number of critical factors:6

  • Planning and collaboration
  • Implementing safe processes
  • Complying with the recommendations made by authoritative institutions
  • Continuous staff training
  • Education for patients and their families and caregivers
  • Constant supervision of the whole system


Easy access to current and accurate drug information

Implementing sources of trustworthy drug-related information is also essential to the development of a safe, quality-driven patient medication system. Complete and evidence-based information helps to support the analysis, interpretation, and presentation of patient results and needs.6

Pharmacists and other key care stakeholders need to be able to quickly and easily consult a source of information, within their workfow, that is kept constantly accurate and up-to-date. This is especially true when dealing with new drugs and treatments. Because new drugs may not be used frequently, it is important to provide some level of evidence or recommendations, especially if the medication is not included in the hospital’s drug therapy guide. Such information should always be available for all professionals before they prescribe, dispense, or administer any medication.7


Patient education that drives adherence

Research shows that treatment compliance and patient satisfaction are higher in cases where patients are

provided with basic, clear, and easy-to-read instructions about the medication they have been prescribed.7 That’s why effective patient drug education is a significant need for a holistic, safe medication system.

Patient education processes can be implemented for drugs prescribed during a hospital admission, at discharge, or in an outpatient setting. The goals are to ensure patients use medications in a safe way and that they are given opportunities to talk about any doubts or questions they may have.7

To recap, improved patient medication safety is an attainable goal in today’s healthcare. The remedy for errors lies in understanding that quality care and patient safety are based on not only direct involvement of all stakeholders, but also implementing better processes — including providing reliable information tools that support clinical and patient decision-making.

“Errors can be prevented by designing our work systems so that errors are diffcult to make. This is the essence of the systems approach to error reduction: focus on the processes, not on the people.”
Lucian L. Leape

Global Health Policy Innovator
Adjunct Professor of Health Policy
Harvard University


  1. U.S. Department of Health & Human Services press release, Dec. 2, 2014, “Efforts to improve patient safety result in 1.3 million fewer patient harms, 50,000 lives saved and $12 billion in health spending avoided,” http://www.hhs.gov/about/news/2014/12/02/efforts-improve-patient-safety-result-1-3-million-fewer-patient-harms-50000-lives-saved-and-12-billion-in-health-spending-avoided.html
  2. World Health Organization study, “IBEAS: a pioneer study on patient safety in Latin America,” 2011, http://www.who.int/patientsafety/research/ibeas_report_en.pdf
  3. Sociedad Española de Farmacia Hospitalaria (SEFH), http://www.sefh.es/normas/errores_meditacion.pdf
  1. National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP)
  2. Instituto Para El Uso Seguro De Los Medicamentos, Delegación Española del Institute for Safe Medication Practices, http://www.ismp-espana.org/estaticos/view/19
  3. Estándares Para Certificar Hospitales 2015, Segunda Edición Consejo de Salubridad General México, Sistema Nacional de Certificación de Establecimientos de Atención Médica 64-67
  4. Errores de Medicación/Recomendaciones para aplicar a corto plazo, 736, http://www.sefh.es/bibliotecavirtual/fhtomo1/cap214.pdf

NEW! Free Latin American Clinical Webinar Series:

Truven Health is hosting free webinars on key topics that pharmacists and other healthcare professionals in Latin America have identifed as areas of interest for further training to help support their daily roles and help improve outcomes. Register now to reserve your place: micromedex.com/LatAmWebinars

Why Attend?

  • Focused on key topics to support your role
  • Tailored for Latin America
  • Hosted by clinical and editorial experts
  • Available with Portuguese or Spanish subtitles
  • Only 30 minutes out of your day

The Significance of Drug Interactions in Latin America: What’s the Real Impact?

Understanding the clinical and financial burden of preventable, drug-interaction adverse events in Latin America will enable practitioners to gain a greater awareness of the value they can provide to improve patient safety. Join our clinical expert to take a closer look at drug interactions and their effects, to build a clearer picture of the real impact.

Tuesday 25 October

Intervening More Effectively in Drug Interactions: How to Best Use the Evidence for Patient Safety

A crucial part of a pharmacist’s role is checking for drug interactions when assessing a patient’s medications, but how can you best use that information to optimize treatment? In this session, you’ll learn how to most effectively care for the patient when the evidence indicates potential interactions.

Wednesday 9 November

Can You Trust the Evidence? Tips for Evaluating Clinical Studies

With tens of thousands of clinical journal articles published each week, it’s essential to understand which are valid and which are flawed when making treatment decisions. Join this webinar to understand the key areas of focus to determine whether a study is methodologically sound, to help you make clinical decisions with confidence.

Tuesday 29 November

at micromedex.com/LatAmWebinars
Customer Focus

Drug Interactions Screening:

One Hospital’s Search for Greater Effciency

Accredited by the Joint Commission International (JCI) and considered the best hospital in Rio de Janeiro1, Hospital São Vicente de Paulo has integrated Micromedex Solutions into its hospital information system (HIS). André Mallman, the hospital’s IT and Telecom Manager, talks to Truven Health about how this has benefited the hospital by automating manual processes and facilitating access to reliable, relevant, evidence-based information.

André Mallman

IT and Telcom Manager

What challenges do you face in your job?

As IT Manager, my job is to seek to improve the effciency of administrative and care processes using technology. The challenge lies in consolidating different needs and solutions into a single platform that facilitates the roles of doctors, pharmacists, nurses, managers, and administrative staff.

How did the relationship with Truven Health begin?

I was introduced to Micromedex by the hospital’s pharmacy team. I found the tool to be practical and of significant relevance for the healthcare team. The possibility of integration within the HIS was of particular interest to me because of the time it would save the health professionals. I got in contact with Truven Health, and we began to talk.

Did the solution facilitate the hospital’s drug interaction processes?

Before Micromedex was integrated, the pharmacists had to enter the information on drug interactions into the HIS manually. A lot of time was being wasted on this activity, and it was impossible to keep this information up-to-date. Now, you can see a patient’s drug interaction profle in a matter of seconds — you can do it for all of the hospital’s patients — and the information is automatically updated. This saves the healthcare professionals time, which they can dedicate to the patient.

What is the greatest benefit this solution has brought your hospital?

Efficiency, which in turn is reflected in the increased quality of patient care and safety. One benefit leads to others.

What are some of the features of the solution?

Drug interactions are automatically displayed to the doctors when writing prescriptions and can be consulted at any time by the pharmacists. Various types of interactions are shown, such as medication-food, medication-tobacco, and use during pregnancy and breastfeeding, among others. The interactions are classed according to level of severity and documentation, which helps when deciding which interaction is most relevant and requires more urgent management. In addition, each professional can configure their own filters to avoid receiving excessive warning messages. Also, Micromedex drug information can be accessed easily through your mobile phone.

Who else benefits from the use of Micromedex?

At the end of the day, the patients are the ones who really benefit, even if they don’t realize it, as their safety and care are enhanced through the presence of a tool that provides critical, relevant information for use in their caregivers’ work processes. But the healthcare providers (doctors, nurses, pharmacists, etc.) themselves benefit through the optimization of their time spent searching for answers to day-to-day clinical questions.

How does Micromedex support the needs of your hospital?

Healthcare costs have increased (partly due to adverse events), and the hospital needs to control these, while at the same time guaranteeing the quality of care provided. Avoiding an interaction that could cause bleeding in a patient, confirming the correct dose of a medication, and ensuring that reliable information is only a click away for the health professionals are all features and results of the use of Micromedex that help the hospital reach its targets.

Would you recommend Micromedex?

Definitely. In addition to the excellent quality of the information provided by Micromedex and the features it provides, the Truven Health team gives us a lot of support.

All client examples cited or described are presented as illustrations of the manner in which some clients have used IBM products and the results they may have achieved. Actual environmental costs and performance characteristics will vary depending on individual client configurations and conditions.

1 List of Latin America’s Top Hospitals and Clinics 2015, América Economía Intelligence,

Hospital Profile:

Hospital São Vicente de Paulo

500+ doctors

50+ medical and
surgical specialties

7,800+ patients
admitted annually

104 inpatient beds, 20 beds
in the Intensive Care Unit

“Avoiding an interaction that could cause bleeding in a patient, confirming the correct dose of a medication, and ensuring that reliable information is only a click away — all are features and results of the use of Micromedex that help the hospital reach its targets.”

Take the Quiz for Your Chance to Win

We invite you to take part in this issue’s clinical knowledge quiz for the chance to win an iPod® Nano!®

If you have access to Micromedex Solutions, use it as a reference for finding the answers to the quiz. Then check your answers at micromedex.com/Nov2016Quiz. If you don’t have access to Micromedex, contact your local representative to find out how you can preview the content. Contact information is located on the last page of this issue.

In December, we’ll randomly select a winner from quiz participants to receive the iPod Nano.

  1. Based on current evidence, which of the proton pump inhibitors interacts with clopidogrel? TIP: Insert all of these medications in the Drug Interactions tool within Micromedex
    1. Pantoprazole
    2. Lansoprazole
    3. Omeprazole
    4. Dexlansoprazole
    5. None of the above
  2. Enalapril is known to cause hyperkalemia. What is the incidence?
    1. 0.1% to 1%
    2. 1% to 3.8%
    3. 5% to 10%
    4. 20%
    5. 56%
  3. Which proton pump inhibitors is/are likely to lead to a vitamin B12 de fiiency? TIP: Search Micromedex for “Drugs that cause vitamin B12 deficiency”
    1. Dexlansoprazole
    2. Lansoprazole
    3. Omeprazole
    4. Rabeprazole
    5. All of the above
  1. Warfarin and levo oxacin are known to interact and may increase the risk of bleeding. What is the suggested option for managing this interaction?
    1. No preemptive warfarin dose reductions are needed, in general
    2. If maintaining both drugs, one should monitor warfarin serum concentration
    3. If maintaining both drugs, monitoring INR is not necessary
    4. Consider the use of another antibiotic, such as ciprofloxacin
    5. None of the above
  2. What is the probable mechanism for the interaction between warfarin and levo oxacin?
    1. Inhibition of warfarin metabolism
    2. Disruption of vitamin K synthesis
    3. Additive effects of both drugs on bleeding
    4. Absorption of warfarin enhanced by use of levofloxacin
    5. Unknown
Check Your Answers
at micromedex.com/Nov2016Quiz
Enter for the chance to win an iPod Nano!
Clinical Content Updates

New Toxicology Content on Dengue Fever Available in Micromedex

Dengue fever remains a public health problem in the Americas despite efforts to stop and mitigate the impact of epidemics. New information concerning the toxicological management of dengue fever has been added to Micromedex Solutions, including clinical effects, laboratory and monitoring information, treatment evidence, range of toxicity, pathology, and more. This complements the evidence-based drug and disease content already present to help treat the mosquito-borne illness.

To view the full list of clinical content updates, visit micromedex.com/clinicalupdates/Oct2016.

What Do Poison Control Centers in Latin America Use for “Evidence-Based Toxicology Information?

Puerto Rico Poison Control Centre

2 toxicology specialists, 15 doctors and nurses

1 supervisor, 1 educator

6,000+ calls received annually

44% of calls are resolved without requiring a hospital visit, helping to relieve emergency departments

Marisol Andino Rodriguez, RN, SPI, and Supervisor at the Poison Control Centre of the Administración de Servicios Médicos de Puerto Rico, speaks to Truven Health about the importance of a trusted, evidence-based tool to support toxicology treatment decisions with confidence

The Puerto Rico Poison Control Centre was established in 1997 by toxicologist Dr. Andrés Britt. The organization provides support services in the event of poisoning via a hotline (1-800-222-1222) 24 hours a day, seven days a week. All calls are attended by specialists in toxicology who provide step-by-step guidance on what to do, and if necessary, where to go, to receive immediate medical attention.

This service is free, and it receives calls from the general public and health professionals for consultations on poisonings or possible intoxications.

Cases of poisoning are more common than you would imagine. Most of these occur in the household, and 90 percent can be prevented. The centre operates with an Educational Poison Prevention Activity Programme, depending on the cognitive level, for the entire Puerto Rican population.

The information offered to the patients and health professionals we deal with is supported by Micromedex Solutions from Truven Health, which is used for every call we receive. Micromedex provides us with vital poisoning treatment information, such as clinical effects, monitoring of signs and symptoms, laboratory, toxicity range, observation time, patient disposition, and the specific dose to be administered when using antidotes. Micromedex is kept up-to-date to ensure the most reliable content possible.

This source of knowledge allows us to feel secure when managing and treating our patients. For the last 18 years that we have been using Micromedex, it has helped us save lives and has helped our patients fully recover.

Kate Elbro from Truven Health Analytics and Ruben Omar from approved local distributor Rubali Professionals Inc. visit the Puerto Rico Poison Control Centre.

All client examples cited or described are presented as illustrations of the manner in which some clients have used IBM products and the results they may have achieved. Actual environmental costs and performance characteristics will vary depending on individual client configurations and conditions.

Product Updates

The Latest Product Updates From Micromedex Solutions

The Federal Pharmacy Council in Brazil (CFF) and the Brazilian Medicines Information Centre (CEBRIM) Support Inclusion of Drugs Approved by Brazil’s National Health Surveillance Agency (ANVISA) in Truven Health’s Micromedex Solution for Automated Medication Interactions Screening

With exclusive support from CFF and CEBRIM to develop local Latin American drug summary information, the integrated Medication Advisory Screening (MAS) module from Micromedex now includes ANVISA-approved medications to support local decisions and screens up to 13 types of interactions, including drug-drug, drug-food, drug ethanol, drug-laboratory, drug-tobacco, drug- pregnancy, drug-lactation, drug-allergy, ingredient duplication, and more.

The evidence used to support the integrated tool is the same content as in Micromedex online, helping clinicians make decisions with confidence using clinically consistent, current information. Inclusion of Brazilian drugs in the interactions screening will help to improve patient safety, enhance patient care outcomes, and help to reduce the costs associated with adverse drug events.

Key Features

Micromedex Solutions are used by 5,500+ healthcare organizations in over 85 countries, including Latin America. And with the integrated, evidence-based solution available through almost all electronic health records (EHRs), medications can be screened for all patients across the hospital, clinic, or ambulatory care setting, directly within the clinical workflow.

Critical information:

Automated screening for harmful drug interactions

Local knowledge:

Includes interactions with ANVISA-approved drugs

Comprehensive coverage:

Screening for up to 13 types of drug interactions

Current content:

Evidence automatically updated regularly

Trusted evidence:

The same trusted, clinically consistent content available via Micromedex online

Timely information:

Evidence available at the point of care, in the decision-making workflow, directly within the EHR

Customer support:

Dedicated implementation support and tailored training on how to make the best use of the information available

Tips & Tricks

Combat Alert Fatigue:
Filter Drug Interaction Severities and Documentation Strength in Micromedex Solutions

In the digital clinical environment, clinicians can receive a staggering number of alerts, which can cause alert fatigue and put patient safety at risk. That’s why it is an industry best practice to minimize alert fatigue by setting up filters based on interaction severity and documentation strength, as well as using alerts based on human factors, considering color and format of the alerts.

Introduction to Interactions Checking in Micromedex

The online version of Micromedex can be used to check all known interactions for a single drug, or you can screen interactions for a list of drugs. When Micromedex is integrated into the EHR, clinicians can automatically screen medications for drug interactions for all patients across the hospital, clinic, or ambulatory care setting, directly within the clinical workflow. Patient drug allergies can also be added to the interaction check.

Interactions Types

Results are grouped by interaction types: drug-drug, drug-food, drug-ethanol, drug-laboratory, drug-tobacco, drug-pregnancy, drug-lactation, drug-allergy, and ingredient duplication. Further interaction types for patient-specific information are available in the integrated product. Interactions found within each type are ranked by severity, with color-coded icons and one-word definitions for clarity. Any interaction marked Contraindicated is displayed first, followed by Major, Moderate, and Minor.

Documentation Ratings

The amount and strength of documentation available for the interaction is also shown. A complete legend of all documentation ratings is shown at the bottom of the page. Hovering over the rating in the legend opens a pop-up with the full definition.

Severity Definitions


The drugs are contraindicated for concurrent use.


The interaction may be life-threatening and/or require medical intervention to minimize or prevent adverse effects.


The interaction may result in exacerbation of the patient’s condition and/or require an alteration in therapy.


The interaction would have limited clinical effects. Manifestations may include an increase in the frequency or severity of side effects, but generally would not require a major alteration in therapy.



Documentation Ratings


Controlled studies have clearly established the existence of the interaction.


Documentation strongly suggests the interaction exists, but well-controlled studies are lacking.


Available documentation is poor, but pharmacologic considerations lead clinicians to suspect the interaction exists, or documentation is good for a pharmacologically similar drug.



Try it in Micromedex!

Filtering Interactions by Severity and Documentation Strength

The Severity drop-down menu allows you to filter interactions by level of severity. De-select (uncheck) any severity you wish to remove, then click the Update button. Use the Documentation drop-down menu to filter for results with specific documentation strengths. This feature is available in the online and integrated versions of Micromedex.


Event Recaps

Truven Health 2016 Puerto Rico Summit

On September 1, Truven Health hosted its third Puerto Rico Summit in San Juan. The lively discussion and speakers included representatives from:

  • Puerto Rico Department of Health
  • The Joint Commission (TJC) Resources
  • Puerto Rico Hospital Association
  • Hospital Español Auxilio Mutuo

During this one-day conference, we discussed in detail the ongoing Centers for Medicare & Medicaid Services (CMS) shift from volume to value payments, including recent proposed changes that will update Medicare payment policies under the Inpatient Prospective Payment System and the Long-Term Care Hospital Prospective Payment System. We heard from industry specialists about trends in hospital quality improvement, and how the latest CMS proposal affects the alignment of Core Measures requirements with electronic clinical quality measures reporting, with particular focus on:

  • How to navigate, in Puerto Rico, the challenges presented by the shift to electronic measures reporting
  • Requirements, measures, and expectations of both CMS and TJC
  • How to improve clinical quality performance in line with the shift from volume to value

Guests had the chance to network, and during educational breakouts, ask questions of subject matter specialists, including the event sponsors, Rubali Professionals Inc. and SabiaMed Corporation.

Visit truvenhealth.com/PRsummit2016 to review speaker bios and presentation slides, ask questions of the speakers, provide your views and feedback, view photos, and find more useful information.

II National Symposium of Hospital Pharmacies
“Research in Hospital Pharmacies: A Tool for Action”
Cholula Puebla, Mexico | 1-2 July 2016

This symposium featured a multidisciplinary forum among doctors, nurses, pharmacists, and all those involved in patient care, with discussions and presentations on advances in hospital pharmacoepidemiology, medication error prevention, hospital certification, the economics of health, and pharmacovigilance.

Experiences from different hospitals were shared, and areas for research opportunity, process optimization, and innovation in hospital pharmaceutical materials were particularly noted. The guiding concept was that hospital pharmacy services should not operate like a stockroom or drugstore, but like an ensemble of clinical services operated by professionals who are experts in medication — promoting the importance of the rational use of medication and patient safety.

Micromedex Solutions had an information stand at the event and participated in the Hospital Certification MMU workshop with the following presentation: “Errors in Medication and Prevention Using Micromedex Solutions as a Clinical Decision-Making Tool.”


Upcoming Events

If you plan to attend any of these events and would like to meet the Micromedex team, please let us know (contact information on back page of this issue).

Puerto Rico Medical Directors Academy

Dorado, Puerto Rico
21-23 October 2016

II SINDIHOSPA Hospital Pharmacy Seminar

Porto Alegre, Brazil
27 October 2016

Philips Connect Day

São Paulo, Brazil
31 October-1 November 2016

XII World Congress of Portuguese-Speaking Pharmacists

Gramado, Brazil
8-10 November 2016

XVI Congreso Argentino de Farmacia Hospitalaria in conjunction with III Simposio Internacional de Educación para la Farmacia Hospitalaria

Buenos Aires, Argentina
9-12 November

IV National Congress for Private Hospitals (CONAHP)

São Paulo, Brazil
16-18 November 2016

Want more content like this?

Subscribe to receive the next issue!

Visit micromedex.com/latam/subscribe

Interested in Micromedex?

Contact us for more information via micromedex.com/LatAm/ContactUs

Contact Info

Your Latin American Team

Latin America Regional Director

Truven Health Analytics, an IBM Company

Jorge Manosalva

Argentina, Chile, Colombia, Peru,
Uruguay, and Venezuela

Dot.Lib, Approved Distributor

Miguel Garcia


Dot.Lib, Approved Distributor

Henrique Pereira

Jorge Siqueira

Caribbean and Central America

Rubali Professionals Inc., Approved Distributor

Ruben Omar


Dot.Lib, Approved Distributor

Clara Manosalva


Dot.Lib, Approved Distributor

Napoleon Villanueva

María del Carmen López Zamora